HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raitis Bobrovs Selected Research

5-Lipoxygenase-Activating Protein Inhibitors

11/2022Exploring Aspartic Protease Inhibitor Binding to Design Selective Antimalarials.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raitis Bobrovs Research Topics

Disease

3Malaria
11/2022 - 09/2018
1Parkinson Disease (Parkinson's Disease)
06/2022
1Prion Diseases (Transmissible Spongiform Encephalopathies)
09/2021
1Thyroid Neoplasms (Thyroid Cancer)
11/2020
1Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1Infections
01/2020

Drug/Important Bio-Agent (IBA)

2plasmepsin (plasmepsin I)IBA
11/2022 - 02/2019
2Amyloid (Amyloid Fibrils)IBA
06/2022 - 09/2021
2Antimalarials (Antimalarial Agents)IBA
02/2019 - 09/2018
2Pharmaceutical PreparationsIBA
02/2019 - 09/2018
15-Lipoxygenase-Activating Protein InhibitorsIBA
11/2022
1Peptide Hydrolases (Proteases)FDA Link
11/2022
1alpha-SynucleinIBA
06/2022
1Prion ProteinsIBA
09/2021
1PrionsIBA
09/2021
1cabozantinibIBA
11/2020
1Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA
11/2020
1FluorineIBA
11/2020
1sortase AIBA
01/2020
1EnzymesIBA
01/2020
1Virulence Factors (Pathogenicity Factors)IBA
01/2020